Moderna Begins COVID-19 Vaccine Trials for Infants and Children

Moderna Begins COVID-19 Vaccine Trials for Infants and Children
Students wear masks as they work in a fourth-grade classroom, at Elk Ridge Elementary School in Buckley, Wash., on Feb. 2, 2021. Ted S. Warren/AP Photo
Meiling Lee
Updated:

Pharmaceutical company Moderna says that the first dose of its CCP virus vaccine has been given to children aged six months to 11 years in a trial called the KidCOVE study.

“This pediatric study will help us assess the potential safety and immunogenicity of our COVID-19 vaccine candidate in this important younger age population,” said Moderna CEO Stéphane Bancel in a press release on Monday.